Grove Bank & Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,263
Closed -$206K – 588
2023
Q3
$206K Buy
1,263
+963
+321% +$169K 0.04% 206
2023
Q2
$55K Buy
300
+275
+1,100% +$39.6K 0.01% 357
2023
Q1
$3.33K Hold
25
– – ﹤0.01% 603
2022
Q4
$2K Buy
+25
New +$1.76K ﹤0.01% 564

Other funds holding ACLS

Grove Bank & Trust's ACLS Position: Q4 2023 in Review

Grove Bank & Trust sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 1,263 shares — an estimated $206K sold.

Grove Bank & Trust first reported a position in ACLS in Q4 2022 and held it in 4 quarters. The position peaked at $206K in Q3 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Grove Bank & Trust reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Grove Bank & Trust sold 1,263 Axcelis shares in Q4 2023, an estimated $206K.
  • Grove Bank & Trust first reported a position in Axcelis in Q4 2022 and held it in 4 quarters.
  • Grove Bank & Trust's Axcelis position peaked at $206K in Q3 2023.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.